|
Market Closed -
Nasdaq
00:00:00 20/10/2026 +04
|
Pre-market 03:00:00 | |||
| 89.21 USD | +1.71% |
|
88.29 | -1.03% |
| 09-12 | Biontech Insider Sold Shares Worth $1,974,287, According to a Recent SEC Filing | MT |
| 09-10 | European Equities Traded in the US as American Depositary Receipts Drop in Thursday Trading | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 22.03B | - | ||||
| 65B | |||||
| 51.2B | |||||
| 51.19B | |||||
| 43.93B | |||||
| 41.96B |
- Stock Market
- Stocks
- BNTX Stock
- Charts BioNTech SE
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
